info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

TIGIT Inhibitors Market By Therapy Type (Monotherapy, Combination Therapy); By Cancer Indication (NSCLC, Triple-Negative Breast Cancer, Melanoma, Head & Neck Cancer, Others); By Route of Administration (Intravenous, Others); By End User (Academic Cancer Centers, Oncology Clinics, CROs, Specialty Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TIGIT Inhibitors Market will witness a strong CAGR of 22.6%, valued at $0.42 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Cytotoxic Drugs and HPAPI Manufacturing Market By Product Type (Cytotoxic Drugs, HPAPIs); By Application (Oncology, Autoimmune Disorders, Others); By Manufacturing Approach (In-House Manufacturing, Outsourced Manufacturing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cytotoxic Drugs and HPAPI Manufacturing Market is expected to register a CAGR of 8.6%, growing from USD 21.7 billion in 2024 to USD 35.6 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Complement Inhibitors Market By Product Type (Monoclonal Antibodies, Small Molecules, RNA-based Therapies, Others); By Indication (Hematology, Nephrology, Neurology, Ophthalmology, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online/Direct Distribution); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement Inhibitors Market is anticipated to register a steady CAGR of 9.8%, expanding from USD 8.6 billion in 2024 to USD 15.1 billion by 2030, support... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

EZH2 Inhibitors Market By Drug Type (Tazemetostat, CPI-1205, Valemetostat, Others); By Indication (Follicular Lymphoma, Epithelioid Sarcoma, Prostate Cancer, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global EZH2 Inhibitors Market is poised for strong momentum at a CAGR of 17.9%, valued at USD 815.2 million in 2024 and projected to reach USD 2.19 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Antiemetics Drugs Market By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Dopamine Antagonists, Cannabinoids & Others); By Application (Chemotherapy-Induced Nausea and Vomiting, Post-Operative Nausea and Vomiting, Motion Sickness & Gastroenteritis, Pregnancy-Induced Nausea); By Route of Administration (Oral, Injectable, Transdermal & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiemetics Drugs Market is projected to expand steadily between 2024 and 2030. The market is valued at USD 6.8 billion in 2024 and is expected to reach <... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Pulmonary Arterial Hypertension Market By Drug Class (Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase-5 Inhibitors, Soluble Guanylate Cyclase Stimulators, Emerging Therapies); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Arterial Hypertension (PAH) Market is projected to grow steadily between 2024 and 2030, moving from USD 8.7 billion in 2024 to approximately USD 13.5 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Specialty Generics Market By Product Type (Injectables, Oral Modified-Release Formulations, Inhalable Generics, Ophthalmic Generics, Others); By Therapeutic Area (Oncology, Autoimmune Disorders, Cardiology & Respiratory, Neurology, Others); By Route of Administration (Injectable, Oral, Inhalation, Topical & Ophthalmic); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Specialty Generics Market is forecast to grow at a CAGR of 8.1%, valued at USD 75.6 billion in 2024 and projected to reach USD 120.8 billion by 2030, supp... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Tramadol Market By Product Type (Immediate-Release, Extended-Release, Injectable, Combination Drugs); By Application (Orthopedic Pain, Cancer Pain, Post-Surgical Pain, Neuropathic Pain); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tramadol Market will expand at a CAGR of 6.5%, valued at USD 2.4 billion in 2024, and expected to reach USD 3.50 billion by 2030, driven by pain m... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Bevacizumab Biosimilars Market By Indication (Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online & Retail Pharmacies); By End User (Large Hospitals & Cancer Institutes, Community Oncology Clinics, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bevacizumab Biosimilars Market will witness a robust CAGR of around 17.0 %, valued at approximately USD 3.6 billion in 2024, expected to ... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Wound Gel Market By Product Type (Hydrogel-Based, Antimicrobial, Alginate-Based, Collagen-Based); By Wound Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical Wounds, Burns, Traumatic Wounds); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Wound Gel Market will witness a steady CAGR of 6.2% , valued at $1.58 billion in 2024 , and projected to reach around $2.26 billion by 2030, according to ... Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

Hyaluronidase Market By Product Type (Animal-Derived, Recombinant); By Route of Administration (Subcutaneous, Intravenous, Topical); By Application (Aesthetic Procedures, Oncology, Ophthalmology, Orthopedics, Drug Delivery); By End User (Hospitals, Specialty Clinics, Cosmetic Dermatology Centers, Research Labs, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyaluronidase Market is projected to expand steadily between 2024 and 2030, advancing at a CAGR of 7.8% , with revenues reaching approximately USD... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Contraceptive Drugs Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives, Emergency Contraceptives, Other Hormonal Therapies); By Route of Administration (Oral, Injectable, Transdermal & Vaginal, Implants & IUS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Family Planning Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Contraceptive Drugs Market will expand at a steady pace between 2024 and 2030, with an estimated value of USD 16.9 billion in 2024 and projected to reach around US... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Dental Cleansing Tablet Market By Product Type (Standard Effervescent Tablets, Multi-Action Tablets, Natural and Eco-Friendly Tablets); By Application (Dentures, Orthodontic Aligners & Retainers, Sports Mouthguards & Sleep Appliances); By Distribution Channel (Retail Pharmacies, Online/E-commerce, Supermarkets & General Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dental Cleansing Tablet Market will witness a robust CAGR of 6.8%, valued at USD 3.2 billion in 2024 , expected to appreciate and reach USD 4.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Vyvgart (Efgartigimod) Market By Indication (gMG, CIDP, ITP, Pemphigus Vulgaris & Foliaceus, Myositis, Nephrology Disorders); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Outpatient Clinics, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vyvgart (Efgartigimod) Market is projected to grow at a CAGR of 32.8% , reaching approximately USD 6.1 billion b... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Pharmaceutical Isolator Market By Type (Open Isolators, Closed Isolators, Modular & Robotic Isolators); By Application (Sterile Manufacturing, Research & Development, Quality Control & Testing, Cytotoxic & HPAPI Handling); By End User (Pharmaceutical & Biotechnology Companies, CDMOs, Academic & Research Institutes, Hospitals & Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Isolator Market is forecast to witness steady growth between 2024 and 2030, expanding from USD 6.2 billion in 2024 to USD 9.8 billion by 2030, at a ... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Small Molecule CDMO Market By Service Type (API Development & Manufacturing, Drug Product Formulation, Packaging Services); By Molecule Type (Innovative Small Molecules, Generic Small Molecules); By Phase of Development (Early-Phase Development, Late-Phase and Commercial Manufacturing); By End User (Large Pharmaceutical Companies, Mid-Sized Pharma, Emerging Biotech, Generic & Specialty Pharma); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule CDMO Market will grow from USD 67.5 billion in 2024 to nearly USD 108.4 billion by 2030, advancing at a CAGR of 8.2%, driven by pha... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Drug Discovery Outsourcing Market By Service Type (Preclinical Services, Clinical Trials Services, Discovery Chemistry & Biology Services, Regulatory and Clinical Development Services); By Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Discovery Outsourcing Market is projected to increase from USD 9.4 billion in 2024 at a sustained CAGR of 7.2% until 2030, attaining USD 14.3 billion by 2030<... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Artificial Tears Market By Product Type (Preservative-Free, Gel-Based, Traditional); By Distribution Channel (Retail Pharmacies, Online, Hospitals and Clinics); By End User (Individuals with Dry Eye Disease, Healthcare Providers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Tears Market is expected to grow from USD 4.5 billion in 2024 to USD 7.63 billion by 2030, registering a CAGR of 9.2%, supported by rising adop... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Dry Powder Inhaler Market By Product Type (Single-Dose Inhalers, Multi-Dose Inhalers, Pre-filled Inhalers); By Application (Asthma, COPD, Other Pulmonary Diseases); By End User (Hospitals, Clinics, Homecare, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Powder Inhaler Market is expanding due to increasing prevalence of chronic respiratory conditions, asthma management, COPD treatment devices, ... Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Small Molecule Drug Discovery Market By Drug Type (Targeted Therapy Drugs, Chemotherapy Drugs, Other Small Molecules); By Disease Area (Oncology, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders); By Stage of Development (Preclinical, Clinical Development, Commercialized Products); By End User (Pharmaceutical Companies, Biotechnology Firms, CROs, Academic and Research Institutions, Hospitals and Healthcare Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule Drug Discovery Market is projected to grow at a 9.4% CAGR, rising from USD 91.6 billion in 2024 to USD 157.04 billion by 2030, driven by ad... Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Cold Form Blister Packaging Market By Material Type (Aluminum Foil, PVC, Polyamide); By Application (Prescription Pharmaceuticals, OTC Drugs & Supplements, Diagnostic Kits, Others); By End User (Pharmaceutical Manufacturers, Nutraceutical Brands, Diagnostic Kit Makers, Contract Packaging Organizations); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Form Blister Packaging Market is set to grow at a CAGR of 6.2% , reaching approximately USD 8.6 billion by 2030 , up from an estimated USD 5.... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Plant-Based API Market By Product Type (Herbal APIs, Botanical APIs); By Application (Cardiovascular Diseases, Diabetes, Oncology, Metabolic Disorders, Others); By End-User (Pharmaceutical & Biotech Companies, CROs, Academic & Research Institutions, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plant-Based API Market is poised for robust growth, driven by the increasing demand for natural and sustainable alternatives in pharmaceuticals. Valued at USD 4.2 ... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

3D Printed Drugs Market By Technology (Fused Deposition Modeling, Inkjet Printing, Stereolithography); By Application (Personalized Medicine, On-Demand Drug Manufacturing, Oral Solid Dosage Development); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Hospitals & Compounding Pharmacies, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global 3D Printed Drugs Market is projected to grow at a remarkable CAGR of 16.2%, from $410 million in 2024 to $1.04 billion by 2030, driven by technological ad... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Generic Oncology Drugs Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy); By Cancer Type (Breast, Lung, Colorectal, Leukemia, Lymphoma, Others); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Generic Oncology Drugs Market is poised for significant growth, projected to expand at a CAGR of 6.07% from USD 26.07 billion in 2024 to USD 41.2 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Cannabis Testing Market By Testing Type (Potency Testing, Contaminant Testing, Terpene Testing, Residual Solvent Testing); By Methodology (Chromatography, Mass Spectrometry, Immunoassays); By End-User (Cannabis Producers, Dispensaries, Research Organizations, Government & Regulatory Bodies, Consumers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Testing Market is expected to grow steadily from USD 2.5 billion in 2024 to USD 7.6 billion by 2030, with a robust CAGR of 15.2%, driven by incre... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Lyophilized Injectable Drugs Market By Product Type (Biologics, Chemotherapeutic Drugs, Hormones, Other Injectable Drugs); By Application (Oncology, Infectious Diseases, Endocrinology, Other Therapeutic Areas); By End User (Pharmaceutical & Biotech Companies, Contract Manufacturing Organizations, Hospitals & Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lyophilized Injectable Drugs Market is poised for significant growth from 2024 to 2030, projected to expand at a CAGR of 8.5%. Valued at USD 12.3 billion in 2024, it is ex... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Prefilled Formalin Vials Market By Product Type (Single-Use Prefilled Vials, Reusable Prefilled Vials); By Application (Medical & Clinical Diagnostics, Forensic Science, Research & Development); By End User (Hospitals & Healthcare Providers, Research Institutes & Laboratories, Contract Research Organizations, Forensic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prefilled Formalin Vials Market is forecasted to grow at a steady CAGR of 6.5%, rising from USD 400 million in 2024 to USD 600 million by 2030, propelled ... Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Cyclooxygenase-2 (COX-2) Inhibitor Market By Product Type (Prescription, OTC); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Other Inflammatory Diseases); By End User (Pharmaceutical Companies, Hospitals, Retail Pharmacies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclooxygenase -2 (COX -2) Inhibitor Market is projected to grow steadily, with a CAGR of 4.2% , valued at USD ... Read More

Published Date: NOV-2025 | No Of Pages:170 | $ 4485

Softgel Capsules Market By Product Type (Standard Softgel Capsules, Specialty Softgel Capsules); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics and Personal Care); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs, Cosmetics and Personal Care Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Globa l Softgel Capsules Market is poised for steady growth, with a CAGR of approximately 7.5 % , valued at USDRead More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Enteric Softgel Capsules Market By Product Type (Gelatin-Based, Vegetable-Based); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics); By End User (Pharmaceutical Companies, Nutraceutical Companies, CROs, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Enteric Softgel Capsules Market is expected to experience steady growth, with a projected CAGR of 6.2% from 2024 to 2030, rising from a v... Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Oral and Topical Anaesthetics Market By Product Type (Oral Anaesthetics, Topical Anaesthetics); By Application (Dental Procedures, Dermatology, Emergency Medicine, Other Applications); By End User (Dental Clinics, Dermatology Clinics, Hospitals, OTC Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oral and Topical Anaesthetics Market is set to experience notable growth in the coming years, with a projected CAGR of 5.8% from 2024 to 2030. In Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Coccidioidomycosis Market By Treatment Type (Antifungal Drugs, Vaccines); By Diagnostic Method (PCR, Serology, Imaging); By End-User (Hospitals, Pharmaceutical Companies, Research Institutes); By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Coccidioidomycosis Market is on a steady upward trajectory, driven by the increasing recognition of the disease’s burden, the growing need for effective treatments, ... Read More

Published Date: NOV-2025 | No Of Pages:199 | $ 4485

Pharmaceutical Grade Lactose Market By Product Type (Anhydrous Lactose, Monohydrate Lactose); By Application (Oral Solid Dosage Forms, Inhalation Drugs, Others); By End User (Pharmaceutical Manufacturers, CROs, Generic Drug Manufacturers, Academic & Research Institutions, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Grade Lactose Market is projected to witness steady growth, with a compound annual growth rate (CAGR) of 4.2% , valued at USD 2.3 b... Read More

Published Date: NOV-2025 | No Of Pages:200 | $ 4485

Rapid Acting Insulin Market By Product Type (Branded Insulin, Generic Insulin); By Administration Route (Injection Pens, Insulin Pumps, Others); By End-User (Hospitals, Home Care Settings, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rapid Acting Insulin Market is projected to expand at a healthy CAGR of 6.5%, growing from USD 16.5 billion in 2024 to USD 24.5 billion by 2030, fueled by... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Chondroitin Sulfate Market By Source Type (Bovine, Shark, Porcine, Plant-Based); By Application (Dietary Supplements, Pharmaceuticals, Veterinary Medicine, Cosmetics); By End User (Consumers, Healthcare Providers, Veterinary Clinics, Cosmetic Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondroitin Sulfate Market is poised for steady growth, driven by the increasing demand for joint health supplements and the expanding therapeutic applications of chondroi... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

Albumin Market By Product Type (Human Albumin, Recombinant Albumin); By Application (Plasma Volume Expanders, Drug Delivery Systems, Diagnostic Reagents); By End User (Hospitals, Pharmaceutical & Biotech Companies, Research Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Albumin Market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2030, reaching a market value of $8.7 bil... Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Throat Lozenges Market By Product Type (Medicated, Non-Medicated); By Active Ingredients (Menthol, Honey & Herbal Extracts, Others); By Distribution Channel (Pharmacies & Drug Stores, Online Retail, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Throat Lozenges Market will experience steady growth during the forecast period from 2024 to 2030, with a projected CAGR of 5.6 % , estimated to reach a market value of Read More

Published Date: NOV-2025 | No Of Pages:172 | $ 4485

Anti-Infective Agents Market By Product Type (Antibiotics, Antivirals, Antifungals, Antiparasitic Drugs); By Therapeutic Class (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, HIV Antivirals, Antimalarial Agents, Antifungal Agents); By Infection Type (Respiratory, Urinary Tract, Gastrointestinal, Skin, STIs, Others); By End-User (Hospitals, Clinics, Long-Term Care Facilities, Pharmaceutical Companies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anti-Infective Agents Market will experience significant growth from USD 82.3 billion in 2024 to approximately USD 120.5 billion by 2030 , driven by a rob... Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Skin Barrier Market By Product Type (Wipes & Films, Creams & Ointments, Sprays & Liquid Barriers); By Application (Ostomy Care, Wound Care, Incontinence Management, Dermatological Conditions); By End User (Hospitals & Clinics, Home Healthcare, Nursing Homes, Retail Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Barrier Market will witness a steady CAGR of 6.64 % , valued at around USD 1.4 billion in 2024 , and is forecast to reach USD 2.1 billion by ... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Chromatography Accessories and Consumables Market By Product Type (Columns, Syringe Filters, Vials and Caps, Reagents and Solvents, Tubing and Fittings); By Chromatography Technique (Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Ion Chromatography); By End User (Pharmaceutical and Biotech Companies, CROs and CDMOs, Environmental Labs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Accessories and Consumables Market is projected to grow from $5.4 billion in 2024 to over $8 billion by 2030, with a steady CAGR of 5.9%, d... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Long-Acting Insulin Market By Product Type (Insulin Glargine, Insulin Detemir, Insulin Degludec, Others); By Application (Type 1 Diabetes, Type 2 Diabetes); By End User (Hospitals, Clinics, Home Care Settings, Diabetes Care Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long-Acting Insulin Market is projected to grow from USD 32.6 billion in 2024 to USD 46.7 billion by 2030, at a CAGR of 5.3%, driven by the rising diabete... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Antibody-mediated Rejection Prevention Market by Product Type (Monoclonal Antibodies, Plasma Exchange Therapies, Gene Therapies, Other Biological Agents); By Application (Kidney Transplants, Heart Transplants, Liver Transplants, Lung Transplants); By End User (Hospitals & Transplant Centers, Contract Research Organizations, Pharmaceutical Companies, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Antibody-mediated Rejection Prevention Market is poised for significant growth in the coming years. In 2024, the global market will be valued at USD 1.5 billion , with projections indicating it w... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Submucosal Lifting Agent Market By Product Type (Synthetic Agents, Natural Agents); By Application (Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, Polypectomy Assistance); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Endoscopy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submucosal Lifting Agent Market is projected to expand at a CAGR of 7.3% , climbing from an estimated $145 million in 2024 to reach $222 million by 2030 ,... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Hemostatic Gels Market By Product Type (Active Hemostatic Gels, Passive Hemostatic Gels); By Application (Surgical Wound Management, Trauma & Emergency Care, Dental Procedures, Neurosurgery); By End User (Hospitals, Ambulatory Surgical Centers, Military & Emergency Response Units, Dental Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemostatic Gels Market is projected to expand at a CAGR of 6.4% , reaching $1.62 billion by 2030 , up from an estimated $1.1 bill... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Progesterone Market By Product Type (Oral Tablets, Injectables, Topical Preparations); By Application (Infertility Treatment, Hormone Replacement Therapy, Other Applications); By End User (Fertility Clinics, Hospitals, Pharmaceutical Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Progesterone Market will witness consistent expansion at a CAGR of 6.3%, growing from $4.6 billion in 2024 to $7.2 billion by 2030, supported by h... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

CIS Insulin Market By Product Type (Human Insulin, Insulin Analogs [Basal, Prandial, Premixed]); By Route of Administration (Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The CIS Insulin Market will witness a robust CAGR of 6.43% , valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 1.68 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Meningococcal Vaccines Market By Vaccine Type (Polysaccharide, Conjugate, Recombinant Protein-Based); By Serogroup Coverage (Monovalent, Bivalent, Quadrivalent, Pentavalent); By Distribution Channel (Public Health Agencies, Hospital Pharmacies, Retail Clinics); By End User (Hospitals, Pediatric Clinics, Military, Travel Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meningococcal Vaccines Market will witness a robust CAGR of 8.4% , valued at $4.7 billion in 2024 , and is expected to appreciate and reach around $7.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Respiratory Syncytial Virus (RSV) Vaccine Market By Vaccine Type (Live Attenuated Vaccines, Subunit Vaccines, mRNA Vaccines, Vector-Based Vaccines, Others); By Target Population (Infants, Older Adults, Pregnant Women, High-Risk Adults, Others); By Route of Administration (Intramuscular, Intranasal, Subcutaneous, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Syncytial Virus (RSV) Vaccine Market will witness a robust CAGR of 17.3% , valued at $2.4 billion in 2024 , and is expec... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Cancer Vaccines Market By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); By Disease Indication (Cervical Cancer, Prostate Cancer, Others); By End-User (Hospitals and Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Vaccines Market is set to experience a robust growth trajectory from 2024 to 2030, driven by increased research and development activities, advancements in biotechn... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Influenza Vaccine Market By Vaccine Type (Inactivated, Recombinant, Live Attenuated); By Age Group (Adults, Children, Elderly); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Influenza Vaccine Market will witness a robust CAGR of 5.1% , valued at $6.3 billion in 2024 , and is expected to appreciate to $8.9 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Carbapenem Market By Product Type (Meropenem, Imipenem-Cilastatin, Ertapenem, Doripenem, Others); By Indication (Respiratory Infections, UTIs, Intra-abdominal Infections, Sepsis, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carbapenem Market will witness a robust CAGR of 5.8%, valued at USD 3.62 billion in 2024 and projected to reach USD 5.07 billion by 2030, driven by rising... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Genitourinary Drugs Market By Drug Class (Hormonal Therapies, Anti-Infectives, Oncology Drugs, BPH Therapies, Erectile Dysfunction Drugs, Overactive Bladder Treatments, Others); By Route of Administration (Oral, Parenteral, Topical/Transdermal, Intravesical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Genitourinary Drugs Market will witness a robust 6.8% CAGR, valued at $45.2 billion in 2024, projected to reach $67.3 billion by 2030, driven by rising Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Subcutaneous Immunoglobulin Market By Product Type (Standard SCIG, High-Concentration SCIG); By Indication (Primary Immunodeficiency Diseases, Secondary Immunodeficiencies, Neurological Disorders, Other Autoimmune Disorders); By End User (Homecare Settings, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Subcutaneous Immunoglobulin (SCIG) Market will witness a robust CAGR of 8.9% , valued at approximately $6.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Shingles Vaccine Market By Vaccine Type (Recombinant Subunit, Live Attenuated); By Route of Administration (Intramuscular, Subcutaneous); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Public Health Agencies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Shingles Vaccine Market will witness a robust CAGR of 8.6% , valued at approximately $4.2 billion in 2024 , and is expected to appreciate and reach nearly $7.0 bil... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Medical Cannabis Market By Product Type (Flowers, Oils & Tinctures, Capsules, Edibles, Topicals); By Application (Chronic Pain, Neurology, Oncology, Mental Health Disorders, Others); By Route of Administration (Inhalation, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Statistical Snapshot - Global Medical Cannabis Market (2024-2030)

  • The Global Medical Cannabis Market is valued at USD 21.3 billion in 2024 and is projected to reach USD 54.7 billion by 2030, expandi... Read More

    Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Biopharmaceutical Excipients Market By Product Type (Binders, Preservatives, Stabilizers, Emulsifiers, Solvents); By Application (Injectable Formulations, Oral Drug Formulations, Vaccines); By End User (Pharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs], Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Excipients Market will experience a solid growth trajectory from USD 7.8 billion in 2024 to USD 11.5 billion by 2030 , reflecting a robust CAGR o... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Cannabis Extract Market By Extract Type (Full Spectrum, Broad Spectrum, Isolates); By Application (Pharmaceuticals, Food & Beverages, Personal Care, Recreational Use); By End User (Medical Users, Adult-Use Consumers, Industrial Buyers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Extract Market will witness a robust CAGR of 18.6%, valued at $12.4 billion in 2024, expected to appreciate and reach $34.2 billionRead More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Alpha Glucosidase Inhibitors Market By Drug Type (Acarbose, Miglitol, Voglibose, Others); By Indication (Type 2 Diabetes Mellitus, Prediabetes, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Glucosidase Inhibitors Market will witness a robust CAGR of 8.1% , valued at $1.32 billion in 2024 , expected to appreciate and reach $2.11 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Bronchodilators Market By Drug Class (Beta-2 Adrenergic Agonists, Anticholinergics, Theophylline, Combination Therapies); By Route of Administration (Inhalation, Oral, Injectable); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Others); By End User (Hospitals, Retail Pharmacies, Homecare Settings, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bronchodilators Market will witness a robust CAGR of 6.7 % , valued at $17.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Sustained Release Excipients Market By Product Type (Polymers [Natural, Synthetic], Coatings [Functional, Osmotic], Minerals, Gums & Lipids); By Formulation Type (Oral Tablets, Capsules, Injectables, Implants); By Route of Administration (Oral, Parenteral, Transdermal, Others); By End User (Pharmaceutical Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sustained Release Excipients Market will witness a robust CAGR of 7.1% , valued at $2.97 billion in 2024 , and is expected to appreciate and reach $4.79 billion by... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

OTC Dry Eye Drops Market By Product Type (Artificial Tears, Lubricant Eye Drops, Gel Drops, Specialty Formulations); By Formulation (Preservative-Free, With Preservatives); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & E-commerce, Supermarkets/Hypermarkets); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global OTC Dry Eye Drops Market will witness a robust CAGR of 6.8% , valued at USD 3.42 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Muscle Relaxant Drugs Market By Drug Class (Centrally Acting Skeletal Muscle Relaxants, Direct-Acting Muscle Relaxants); By Route of Administration (Oral, Injectable); By Application (Musculoskeletal Conditions, Neurological Disorders, Perioperative and ICU Care); By End User (Hospitals, Outpatient Clinics, Rehabilitation Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Muscle Relaxant Drugs Market will witness a robust CAGR of 5.8% , valued at $2.34 billion in 2024, expected to appreciate and reach $3.29 billion by 2030,... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Alpha Emitter Market By Isotope Type (Actinium-225, Radium-223, Astatine-211, Lead-212, Others); By Application (Prostate Cancer, Bone Metastases, Leukemia & Lymphoma, Neuroendocrine Tumors, Others); By End User (Hospitals & Oncology Clinics, Radiopharmacies, Academic Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Emitter Market will witness a strong CAGR of 13.7% , valued at $990 million in 2024 , and is projected to grow significantly to reach around $2.15 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Erythropoietin Drugs Market By Drug Class (Epoetin Alfa, Darbepoetin Alfa, Epoetin Beta, Others); By Application (Chronic Kidney Disease, Cancer, HIV, Surgical Procedures, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erythropoietin Drugs Market will witness a robust CAGR of 8.2% , valued at $ 11.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Inhalable Drugs Market by Product Type (MDIs, DPIs, Nebulizers); By Application (Asthma, COPD, Other Respiratory Disorders); By End-User (Hospitals, Clinics, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inhalable Drugs Market will witness a robust CAGR of 6.3% , valued at $20.5 billion in 2024 , expected to appreciate and reach $3... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Corticosteroids Market By Product Type (Systemic Corticosteroids, Topical Corticosteroids, Inhaled Corticosteroids, Ophthalmic Corticosteroids, Intranasal Corticosteroids); By Route of Administration (Oral, Parenteral, Topical, Inhaled, Ophthalmic, Intranasal); By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Disorders, Ophthalmic Conditions, Endocrine Disorders, Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Corticosteroids Market will witness a robust CAGR of 6.74 % , valued at $16.2 billion in 2024, expected to appreciate and reach $21.4 billionRead More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

PARP Inhibitor Market By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib, Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PARP Inhibitor Market will witness a sustained CAGR of 12.6% , valued at $5.1 billion in 2024 , and is expected to appreciate and reach <... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Antihypertensive Drugs Market By Product Type (ACE Inhibitors, Calcium Channel Blockers, Diuretics, Beta-blockers, ARBs); By Therapeutic Class (Monotherapy, Combination Therapy); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Antihypertensive Drugs Market will experience a steady growth trajectory from 2024 to 2030, driven by the increasing prevalence of hypertension globally, especially among aging populations. The global market for ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Microneedle Flu Vaccine Market By Product Type (Solid, Dissolving, Coated, Hollow); By Route of Administration (Transdermal, Intradermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Vaccination Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedle Flu Vaccine Market will witness a robust CAGR of 18.4% , valued at $516 million in 2024 , expected to appreciate and reach $1.43 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Diphenhydramine Market By Product Type (Branded, Generic); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diphenhydramine Market is projected to expand steadily between 2024 and 2030, growing at a CAGR of 5.8% . Valued at around USD 350 Million In 2024... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Angina Pectoris Drugs Market By Drug Class (Nitrates, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, Ranolazine and Novel Anti-Anginals); By Route of Administration (Oral, Intravenous, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angina Pectoris Drugs Market is on track for robust CAGR of 5.7%, valued at $9.2 billion in 2024 and reaching $12.8 billion by 2030; opportunities span Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Myelodysplastic Syndrome Drugs (MDS) Market By Drug Class (Hypomethylating Agents, Immunomodulatory Drugs, Targeted Therapies, Supportive Care Drugs); By Route of Administration (Oral, Injectable); By End User (Hospitals, Oncology Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myelodysplastic Syndrome (MDS) Drugs Market is poised for long-term growth at a CAGR of 10.1%, valued at USD 2.1 billion in 2024 and forecast to reach USD 3.8 bill... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market By Drug Class (Glycopeptides, Oxazolidinones, Lipopeptides, Cephalosporins, Tetracyclines, Others); By Route of Administration (Oral, Parenteral, Topical); By Indication (Skin and Soft Tissue Infections, Bloodstream Infections, Pneumonia, Bone and Joint Infections, Others); By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutions, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market will witness a promising CAGR of 6.4%, valued at USD 4.73 billion in 2024 and expected to reach USD... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Immune Checkpoint Inhibitors Market By Drug Type (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Others); By Cancer Type (Lung, Melanoma, Bladder, Breast, Liver, Others); By End User (Hospitals & Cancer Centers, Academic Institutes, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Checkpoint Inhibitors Market outlook shows a strong CAGR of 13.8%, expanding from $42.3 billion in 2024 to $102.1 billion by 2030, driven by Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Empty Capsules Market By Capsule Type (Gelatin, Vegetarian, Others); By End-User Application (Pharmaceutical, Nutraceutical, Cosmetic); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Empty Capsules Market is set to grow at CAGR 5.6%, valued USD 5.6 billion in 2024 and reaching USD 7.6 billion by 2030, driven by rising demand for Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Plasma Protease C1-Inhibitor Market By Product Type (Plasma Derived C1 Inhibitor, Recombinant C1 Inhibitor); By Route of Administration (Intravenous, Subcutaneous); By Indication (Hereditary Angioedema, Acquired Angioedema, Other Complement Disorders); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plasma Protease C1-Inhibitor Market is set to witness 7.4% CAGR, expanding from USD 1.14 billion in 2024 to USD 1.75 billion by 2... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

HPV Associated Disorders Market By Product Type (Prophylactic Vaccines, Therapeutic Vaccines, Diagnostic Assays, Topical and Systemic Treatments); By Indication (Cervical Cancer, Genital Warts, Oropharyngeal Cancers, Recurrent Respiratory Papillomatosis); By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Public Health Agencies & NGOs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Statistical Snapshot — Global HPV Associated Disorders Market (2024-2030)

  • The Global HPV Associated Disorders Market is expanding at a CAGR of 7.2%, increasing from USD 4.8 billion in 2024 to USD 7.8 billio... Read More

    Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Postpartum Depression Drugs Market By Drug Class (Selective Serotonin Reuptake Inhibitors, Neuroactive Steroids, Tricyclic Antidepressants, Atypical Antidepressants, Others); By Route of Administration (Oral, Intravenous, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postpartum Depression (PPD) Drugs Market should surge at 28.6% CAGR, valued at $1.72 billion in 2024 and forecast to achieve $7.75 billion by 2030, as Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Anticoagulant Reversal Drugs Market By Drug Type (Vitamin K Antagonist Reversal Agents, Heparin and LMWH Reversal Agents, Direct Oral Anticoagulant Reversal Agents); By Route of Administration (Intravenous, Oral); By End User (Hospitals and Trauma Centers, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anticoagulant Reversal Drugs Market climbs at CAGR 9.2% from $1.24 billion in 2024 to $2.32 billion by 2030, emphasizing DOAC rev... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Hyperlipidemia Drugs Market By Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibrates, Niacin, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hyperlipidemia Drugs Market is poised for CAGR of 6.5%, valued at USD 16.8 billion in 2024 and reaching USD 24.6 billion by 2030, as LDL-C lowerin... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Superdisintegrants Market By Product Type (Synthetic, Natural, Co-Processed); By Formulation Type (Tablets, Capsules, Orodispersible Tablets, Others); By Therapeutic Area (Cardiovascular, Neurological, Gastrointestinal, Infectious Diseases, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Superdisintegrants Market trajectory indicates CAGR 6.94 %, moving from USD 460 million in 2024 to USD 780 million by 2030, as pharmaceutical exci... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Conjugate Vaccine Market By Type (Monovalent, Multivalent); By Disease Indication (Pneumococcal, Meningococcal, Hib, Typhoid, Others); By Age Group (Pediatrics, Adults, Geriatrics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Conjugate Vaccine Market is on track for 8.3% CAGR, from $14.1 billion in 2024 to $22.94 billion by 2030, fueled by PCV innovation, Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Kidney Cancer Drugs Market By Therapeutic Class (Targeted Therapy, Immunotherapy, Combination Therapy, Others); By Disease Stage (Localized RCC, Advanced/Metastatic RCC); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Kidney Cancer Drugs Market to hit $11.9 billion by 2030 from $4.54 billion in 2024 at CAGR 8.7%, shaped... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Immunomodulators Market By Drug Class (Immunosuppressants, Immunostimulants, Monoclonal Antibodies, Interferons, Interleukins); By Route of Administration (Oral, Injectable, Intravenous); By Indication (Autoimmune Diseases, Organ Transplantation, Oncology, Infectious Diseases, Others); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immunomodulators Market is set to grow at a robust CAGR of 8.2%, valued at USD 84.2 billion in 2024 and expected to reach USD 134.7 billion by 2030, drive... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Interleukin Inhibitors Market By Type (IL-1, IL-6, IL-17, IL-23, IL-12/23, IL-4/13, Others); By Indication (Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Asthma, Atopic Dermatitis, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Homecare, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Interleukin Inhibitors Market is set to expand at a robust CAGR of 10.2%, valued at $22.8 billion in 2024 and expected to reach $45.4 billion by 2030, dri... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Congestive Heart Failure (CHF) Drugs Market Congestive Heart Failure Drugs Market By Drug Class (ACE Inhibitors, Beta-Blockers, Diuretics, ARNIs, SGLT2 Inhibitors, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Heart Failure (CHF) Drugs Market will witness a steady CAGR of 5.8%, valued at approximately $14.2 billion in 2024 and expected to reach around $19.8 bi... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Paracetamol Intravenous (IV) Market By Formulation Type (Standard Vial Injection, Ready-to-Use Infusion Bag, Ampoule-Based Formulations); By Application (Postoperative Pain Management, Fever Reduction in Critical Care, Trauma and Emergency Care); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Departments and ICUs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paracetamol Intravenous ( IV ) Market will witness a robust CAGR of 5.8% , valued at approximately $785 million in 2024 , and is expected... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Digestive and Intestinal Remedies Market By Product Type (Antacids, Laxatives, Anti-diarrheal Agents, Probiotics and Prebiotics, Digestive Enzymes, IBS/IBD-Specific Therapies, Herbal and Natural Remedies); By Disease Indication (Constipation, Diarrhea, GERD, IBS, IBD, Lactose Intolerance, Gut Health Maintenance); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Supermarkets, Health & Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digestive And Intestinal Remedies Market is projected to expand at a robust 6.4% CAGR, valued at $42.7 billion in 2024 and expected to reach $62.1 billion by 2030<... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Non-Opioid Pain Patches Market By Product Type (Lidocaine, Capsaicin, Diclofenac, Ketoprofen, Menthol-Based, Others); By Application (Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Post-Surgical Pain, Sports Injuries, Others); By End User (Hospitals & Surgical Centers, Retail Pharmacies, Online Pharmacies, Home Healthcare, Rehabilitation Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Opioid Pain Patches Market will witness a promising CAGR of 8.2 %, valued at $3.1 billion in 2024 , and is expected to appreciate and... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Antipsychotic Drugs Market By Drug Type (Typical, Atypical); By Therapeutic Application (Schizophrenia, Bipolar Disorder, Major Depressive Disorder With Psychotic Features, Other Psychoses); By Route of Administration (Oral, Long-Acting Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antipsychotic Drugs Market is set to grow at a steady CAGR of 4.6%, valued at USD 16.2 billion in 2024 and expected to reach USD 21.22 billion by 2030, dr... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Omega-3 Prescription Drugs Market By Product Type (EPA-Only Formulations, Combination EPA/DHA Formulations); By Application (Severe Hypertriglyceridemia, Cardiovascular Event Risk Reduction, Other Emerging Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Omega-3 Prescription Drugs Market is anticipated to expand at a healthy CAGR of 6.4%, increasing from $2.1 billion in 2024 to $3.1 billion by 2030, driven... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Tumor Necrosis Factor Inhibitor Drugs Market By Product Type (Monoclonal Antibodies, Fusion Proteins, Biosimilars); By Route of Administration (Subcutaneous, Intravenous); By Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriasis, Ulcerative Colitis, Others); By End User (Hospitals & Specialty Clinics, Ambulatory Infusion Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tumor Necrosis Factor Inhibitor Drugs Market will witness a robust CAGR of 7.1% , valued at approximately USD 36.7 Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Liposomal Doxorubicin Market By Product Type (Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin, Non-PEGylated Liposomal Doxorubicin); By Cancer Type (Breast Cancer, Ovarian Cancer, Kaposi’s Sarcoma, Multiple Myeloma, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Liposomal Doxorubicin Market will witness a robust CAGR of 6.9% , valued at $1.42 billion in 2024 , expected to appreciate and reach $2.13 billion... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Pediatric Vaccines Market By Vaccine Type (Inactivated, Live Attenuated, Conjugate, Toxoid, Subunit/Recombinant, mRNA); By Disease Indication (MMR, DTaP, Polio, Pneumococcal, Hepatitis, Rotavirus, Hib, Others); By Route of Administration (Intramuscular, Subcutaneous, Oral); By Distribution Channel (Public Programs, Private Clinics, Hospitals, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Pediatric Vaccines Market is forecast to witness notable expansion at a CAGR of approximately 6.4%, growing from USD 49.3 billion in 2024 to USD 73.9 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Burn Ointment Market By Product Type (Antimicrobial Burn Ointments, Moisturizing Burn Creams, Pain-Relief Burn Gels, Regenerative and Bioactive Formulations); By Burn Severity (Minor Burns, Partial-Thickness Burns, Full-Thickness Burns); By End User (Hospitals, ASCs, Retail Pharmacies and Online, Military and Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Burn Ointment Market will witness a robust CAGR of 6.4% , valued at $1.45 billion in 2024 , expected to appreciate and reach $ 2.5 Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Cholera Vaccines Market By Vaccine Type (Killed/Inactivated, Live Attenuated); By End User (Public Health Agencies, NGOs, Hospitals & Clinics, Military & Travelers); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cholera Vaccines Market will witness a robust CAGR of 8.7% , valued at $113.4 million in 2024 , and is expected to appreciate and reach $186.2 million by 2030Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Enteric Empty Capsules Market By Material Type (Gelatin Capsules, Non-Gelatin Capsules [HPMC and Others]); By Release Mechanism (pH-Dependent Release, Time-Dependent Release, Enzyme-Triggered Release); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enteric Empty Capsules Market will witness a robust CAGR of 4.56 % , valued at USD 995 million in 2024, expected to appreciate and reach about USD... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market By Product Type (Non-Selective COX Inhibitors, COX-2 Selective Inhibitors, Salicylates); By Route of Administration (Oral, Topical, Parenteral); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Chronic Back Pain, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Steroidal Anti-Inflammatory Drugs Market will witness a robust CAGR of 9.78 % , valued at $ 11.23 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Nanocapsules Market By Material Type (Polymeric Nanocapsules, Lipid-Based Nanocapsules, Hybrid Nanocapsules); By Application (Pharmaceuticals, Cosmetics & Personal Care, Food & Nutraceuticals, Agrochemicals, Others); By End User (Pharmaceutical & Biotechnology Companies, Cosmetic Manufacturers, Food & Beverage Companies, Agriculture Sector, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nanocapsules Market will witness a robust CAGR of 13.8% valued at $3.9 billion in 2024, expected to appreciate and reach $8.6 bil... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Allylamines, Others); By Indication (Superficial Fungal Infections, Systemic Fungal Infections); By Route of Administration (Oral, Topical, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antifungal Drugs Market will witness a robust CAGR of 5.7% , valued at approximately $16.3 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485